Amgen ‘very encouraged’ by preliminary data from weight-loss drug trial, stock jumps

Shares of Amgen Inc. rallied in the extended session Thursday after the drugmaker posted adjusted earnings above expectations and executives said they are “very encouraged” by preliminary data from a trial of an injectable weight-loss drug.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnShares of Amgen Inc. rallied in the extended session Thursday after the drugmaker posted adjusted earnings above expecta